Overview

"Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis after failure of a different TNF-alpha inhibitor" prepared by the Technical Lead, Zoe Garrett, NICE

Overview Overview
29 April 2008
(320.62 Kb 33 sec)

This page was last updated: 30 March 2010